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INTRODUCTION
Ischemic stroke is the third leading cause of death in indu-
strially advanced countries and a major cause of long-lasting
disability (Lo et al., 2003). Although a large number of com-
pounds have been proven to reduce ischemic injury, clinical
trials have been unsuccessful because of their toxic side effects.
Thus, the development of new drugs and discovery of novel
mechanisms for treating cerebral ischemia are very much need-
ed (Lipton, 1999). In ischemic strokes, apoptosis is caused by
excitotoxicity, ionic imbalance, oxidative/nitrosative stress, and
apoptotic-like pathways (Zhang et al., 2004). Increase in cal-
cium ions mediated by glutamate receptors causes an ionic
imbalance and the production of reactive oxygen families,
which directly impair lipids, proteins, nucleic acids, and secrete
apoptotic proteins (Love, 1999; Droge, 2002; Lo et al., 2003). 
A main event during ischemia is the generation of free radi-
cals, which provoke damage to lipids, DNA, and proteins and
cause neuronal death (Moro et al., 2004). They also contribute
to the breakdown of the blood-brain barrier and brain edema
(Moro et al., 2004). Nitric oxide (NO) is one of these radicals
and is elevated after ischemic insult (Love, 1999; Paul, 2004).
NO is generated primarily by neuronal and inducible NO syn-
thases (NOS) and promotes neuronal damage followed by ische-
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ABSTRACT In ischemic strokes, apoptosis is caused by excitotoxicity, ionic imbalance, oxidative/nitrosative
stress, and apoptotic-like pathways. Nitric oxide (NO), a free radical, is elevated after ischemic insult. NO, which is
generated primarily by neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS), promotes
neuronal damage following ischemia. Evidence obtained in recent years has demonstrated that endoplasmic
reticulum (ER)-mediated cell death plays an important role in cerebral ischemia. Agmatine is an endogenous substance
synthesized from L-arginine by arginine decarboxylase (ADC) and is present in mammalian brain. We had previously
reported that agmatine contributes to neuroprotection against ischemic injury. In continuation of our earlier work, we
intended to investigate whether agmatine protects brain from transient global ischemia, and also tried to determine the
neuroprotective mechanism of agmatine. Twenty minutes of transient global ischemia was induced by 4 vessel
occlusion (4-VO). Agmatine (100 mg/kg, IP) was administered simultaneously with reperfusion. Samplings of brain
were done at 6, 24, 48, and 72 h after reperfusion to determine the effect of agmatine on ischemic injured hippocam-
pus. ER-damage was also investigated using electron microscope. Results showed that agmatine treatment prevented
delayed neuronal cell death in hippocampal CA1 neurons after global cerebral ischemia. It also blocked NOS
expression in the rat brain. Agmatine induced the increased expression of glucose-regulated protein 78 (Grp78). These
results suggest that agmatine inhibits the production of NO by decreasing the expression of nNOS and iNOS on global
forebrain ischemia and the neuroprotective effect of agmatine were concerned with the ER stress-mediated condition. 
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mia (Love, 1999; Moro et al., 2004; Paul, 2004). Ischemia-
induced NO overproduction is caused in part by glutamatergic-
mediated increase in intracellular calcium concentration, which
results in calmodulin-dependent upregulation of NOS (Moro
et al., 2004; Paul, 2004). NO is enzymatically synthesized
from L-arginine and is massively increased by ischemia (Sastre
et al., 1996). Three NOS have been reported (eNOS, nNOS,
and iNOS), were named according to their originally defined
endothelial (eNOS) and neuronal (nNOS) localizations, or abi-
lity to be upregluated when induced (iNOS) (Moro et al., 2004).
NO has also been shown to inhibit mitochondrial respiration
via competition with oxygen for cytochrome oxidase and plays
an important role in the initiation of apoptosis (Horn & Lim-
burg, 2001; Nomura, 2004). Although little has been reported
on the effects of NO which would warrant them as a subject
of clinical investigation, there is no doubt that NO plays a piv-
otal role in mediating oxidative stress (Warner et al., 2004). 
The endoplasmic reticulum (ER) is the site of protein synthe-
sis and protein folding. Perturbations of ER homeostasis affect
protein folding and cause ER stress (Paschen, 2003). ER can
sense stress and respond to it through translational attenuation,
upregulation of genes for ER chaperones and related proteins,
and the degradation of unfolded proteins by a quality-control
system (Qi et al., 2004b). Evidence obtained in recent years has
demonstrated that ER-mediated cell death plays an important
role in cerebral ischemia (Qi et al., 2004a). Therefore, targeting
the ER may provide a therapeutic approach for blocking the
pathological process induced by cerebral ischemia (Hayashi et
al., 2004). However, no pharmacological approaches for treat-
ing ischemia-induced ER dysfunction have been reported. 
Agmatine, [(NH2(CH2)4NH2C(NH=)NH] is an endogenous
substance synthesized from L-arginine by arginine decarboxy-
lase (ADC) (Tabor & Tabor, 1984) and is present in mam-
malian brains (Li et al., 1994; Raasch et al., 1995). Previous
studies have shown that agmatine may be neuroprotective both
in vitro and in vivo ischemia models (Olmos et al., 1999; Wei
et al., 2002). Agmatine is not a precursor for NOS, but is a
rather weak competitive inhibitor of various NOS isozymes
(Auguet et al., 1995; Galea et al., 1996). NOS generates NO
by sequential oxidation of the guanidinium group in L-arginine,
and agmatine is an L-arginine analogue with a guanidinium
group (Mayer et al., 1989; Gerova & Torok, 2004). This sug-
gests that agmatine may protect the brain from ischemic injury
by interfering with NO signaling. Also, we have previously
studied the effects of agmatine on the middle cerebral artery
occlusion (MCAO) model in mice and reported that agmatine
contribute to neuroprotection against ischemic injury (Kim et
al., 2004).
The typical feature of global ischemia is a brief or interme-
diate occlusion followed by recirculation and long-term reco-
very (Kim et al., 2001; Fukunaga & Kawano, 2003; Katsuta et
al., 2003). Global ischemia, as occurs in cardiac arrest, can
only be sustained upto a period of 12 minutes (Siesjo et al.,
1995). Transient global cerebral ischemia leads to cell death in
hippocampal CA1 pyramidal neurons starting 2~3 days after
reperfusion (Kohno et al., 1997; Gillardon et al., 1999). This
phenomenon is commonly referred to as selective neuronal
vulnerability of delayed neuronal cell death. Several mecha-
nisms, glutamate excitotoxicity, calcium overload, free radical
injury, and disturbances in protein synthesis, have been impli-
cated in ischemia-mediated neuronal cell death and transcrip-
tional activation of various genes has been demonstrated in
postischemic neurons (Iadecola et al., 1995; Lee et al., 2001;
Calderone et al., 2003). 
In this study, we investigated the effects of agmatine and its
NO regulation. We elucidated ER-damage according to the
reperfusion time on neuronal death of transient global cerebral
ischemia in rats. 
MATERIALS AND METHODS
1. Animals 
Male Sprague Dawley rats (300~350 g) from Sam tako,
INC. (Osan, Korea) were used for present study. All animal
procedures were carried out according to a protocol approved
by the Yonsei University Animal Care and Use Committee,
which was in accordance with the NIH guidelines. 
2. Global cerebral ischemia 
The animals were anesthetized with 3% isoflurane and main-
tained during surgery at a level of 2% isoflurane in 70% N2O
and 30% O2 with spontaneous breathing. Twenty minutes of
transient global ischemia was induced by 4 vessel occlusion
(4-VO) using the method described originally by Pulsinelli et
al. (1979). In brief, after the animals were positioned in stereo-
taxic ear bars (Kopf, Tujunga, CA) with the head tilted down
at ~30 to the horizontal, an incision of 1 cm in length was
made behind the occipital bone directly overlying the first two
cervical vertebrae. The paraspinal muscles were separated from
the midline, and the right and left alar foramina of the first cer-
vical vertebrae were exposed using an operating microscope.
A 0.5-mm diameter electrocautery needle was inserted through
each alar foramen and both vertebral arteries were electrocau-
terized and permanently occluded. Next, both common carotid
arteries were isolated via a ventral, midline cervical incision.
An atraumatic arterial clasp was loosely placed around each
common carotid artery without interrupting the carotid blood
flow and the incision was closed with a single suture. On the
following day, 20 min of 4-VO ischemia was induced by tight-
ening the clamp around the common carotid arteries. Carotid
clamps were then removed. Sham-operated animals that under-
went surgery were used for non-ischemic controls. 
Rectal temperature was controlled at 37±0.5�C during sur-
gery with a feedback-regulated heating blanket (Homeothermic
Blanket Control Unit, Harvard apparatus; Edenbridge, UK).
The femoral artery was exposed and catheterized with a PE-50
catheter to allow continuous recording of arterial blood pres-
sure and withdrawal of blood samples for blood gas analysis.
After arterial blood pressure was recovered, arterial blood was
collected for blood gas analysis. 
3. Agmatine administration 
Agmatine was purchased from Sigma (St. Louis, MO, USA)
and dissolved in normal saline. It was administered at a dose
of 100 mg/kg of weight intraperitoneally with reperfusion (Kim
et al., 2004). Control animals received normal saline in equiva-
lent volume. 
4. Histological assessment of ischemic injury 
Histological and immunohistochemical studies were con-
ducted at 6, 24, 48, and 72 hours (each, n=5) after reperfusion.
Animals were perfused transcardially with 200 mL of saline
followed by 300 mL of 4% paraformaldehyde solution and
were decapitated. Brains were removed and postfixed in the
same paraformaldehyde solution for days and then embedded
in paraffin. Five μm sections were cut through the dorsal hip-
pocampus (anteroposterior coordinate, bregma-3.0 mm) on a
microtome. Brain sections were stained with hematoxylin and
eosin (H & E). Neuronal counts in a predesignated region of
CA1 were obtained from four to five animals per condition. 
5. Western blot analysis 
For western blot analysis, animals were sacrificed at 6, 24,
48, and 72 hours (each, n=4) after being exposed to global
ischemia. Brains were perfused through the heart aorta with
cold PBS to rinse out blood, and protein was extracted, as
previously described (Lee et al., 2001). The hippocampus reg-
ion from the rat brain was dissected, homogenized to extract
cellular proteins with lysis buffer containing 1× PBS, 1%
nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, protei-
nase inhibitor (PMSF, aprotinin and sodium orthovanadate) and
centrifuged at 13,000 rpm for 17 min at 4�C. The protein con-
centration in the supernatant was determined by the BCA
method (PIERCE, Rockford, USA).
Western blot analysis was performed using primary antibod-
ies (Table 1). Equal amounts of protein, 40 μg per condition,
were separated on 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels and electrotransferred
onto Immobilon-NC membranes (Milipore, MA), which were
probed with primary antibodies at 4�C overnight and secon-
dary antibodies at room temperature for 1 hour. To reduce non-
specific antibody bindings, the membranes were blocked with
5% nonfat dry milk for 1 hour at room temperature before being
incubated with primary antibodies. Immunoreactive signals
were visualized by chemiluminescence using the ECL detec-
tion system (Amersham Life Science, Buckinghamshire, UK)
with Kodak X-AR film. Immunoblot signals were quantified
using a computer program (GelScopeTM, Imageline INC, CA,
USA) (Lee et al., 2001). 
6. Immunohistochemistry 
Brain sections were fixed with 4% paraformaldehyde and
rehydrated. Sections were immunostained with primary anti-
bodies followed by an appropriate biotinylated secondary anti-
body. Stains were visualized using the ABC kit (Vector Labo-
ratories Inc, CA, USA) (Lee et al., 2001), then reacted with dia-
minobenzidine (DAB) as a substrate (Sigma, St. Louis, USA)
and counterstained with hematoxylin. Results were recorded
with a DP-70 digital camera (Olympus, Japan). 
7. Transmission electron microscopy 
For electron microscopy (EM) studies, animals were sacri-
ficed at 24 hours (each, n=3) after global ischemia. Brains
were perfused through the heart aorta with 2.5% glutaraldehyde
and 2% paraformaldehyde solution. The brain sections were
immersed in a solution containing 3% glutaraldehyde in 0.1M
cacodylate buffer for 1 h, rinsed in cacodylate buffer and post-
fixed for 1 h in 1% OsO4 solution in the same buffer. The fixed
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Table 1. Antibodies used for immunohistochemistry and Western blot 
Protein Format
Concentration
ManufacturerImmuno/WB
nNOS Rabbit polyclonal 1 : 200/- Upstatea
iNOS Rabbit polyclonal 1 : 5000/- Chemiconb
eNOS Rabbit polyclonal 1 : 500/- Transduction 
Labc
Nitrotyrosine Rabbit purified IgG 1 : 200/- Upstatea
Hsp70 Mouse monoclonal -/1 : 1000 Stressgend
actin Mouse monoclonal -/1 : 1000 Santa Cruze
Grp78 Rabbit polyclonal -/1 : 1000 Santa Cruz
GADD153 Mouse monoclonal -/1 : 2000 Santa Cruz
Bcl-2 Rabbit polyclonal -/1 : 1000 Santa Cruz
Immuno, Immunohistochemistry; WB, Western blot 
aLake Placid, NY; bTemecula, CA; cHercules, CA; dVictoria, Canada; eSanta
Cruz, CA 
The Neuroprotective Effect of Agmatine on Rat Global Cerebral Ischemia 152
tissue blocks were then dehydrated through gradient concentra-
tions of ethanol, transferred to propylene oxide, and specimens
were embedded in Epon 812-Araldite. Thin sections for ultra-
structural evaluation were cut on an LKB ultramicrotome with
a diamond knife, contrasted with uranyl acetate and lead citrate,
and examined in a Siemens Elmiskop 102 electron microscope
(Siemens, Berlin, Germany). 
RESULTS
1. The effect of agmatine on delayed neuronal
death after transient global ischemia 
Ischemic neuronal damage in hippocampal neurons with
agmatine treatment following different reperfusion durations
in global cerebral ischemia, as evaluated by H & E stanining,
was less than that in experimental control groups (Fig. 1A).
H & E staining demonstrated that only a few neurons showed
ischemic changes at 6 hours of reperfusion after 20 minutes of
4-VO without agmatine treatment (EC6). Almost all neurons
showed ischemic changes in the CA1 region in a time-depen-
dent manner and many neurons died in the CA1 subfield at 72
hours of reperfusion after 20 minutes of 4-VO without agma-
tine treatment (EC72). Whereas neurons of agmatine treatment
groups were shaped like normal neurons (Fig. 1A). 
2. Long-term effect of agmatine after 
global ischemia 
To investigate the side effects of agmatine, we studied long-
Fig. 1. Neuronal cell death in the rat hippocampus (CA1) was reduced with agmatine treatment following global cerebral ischemia. Hippocampus
(CA1) was stained with H & E following different reperfusion durations in global cerebral ischemia with or without agmatine (A). Physiological
conditions, body weight (B), and body temperature (C) were not significantly different between normal control and agmatine treatment group fol-
lowing global cerebral ischemia. EC6, 6 hours of reperfusion after 4-VO; EC24, 24 hours of reperfusion after 4-VO; E48, 48 hours of reperfusion
after 4-VO; EC72, 72 hours of reperfusion after 4-VO; AGM6, 6 hours of reperfusion after 4-VO with agmatine treatment; AGM24, 24 hours of
reperfusion after 4-VO with agmatine treatment; AGM48, 48 hours of reperfusion after 4-VO with agmatine treatment; AGM72, 72hours of reper-
fusion after 4-VO with agmatine treatment; Normal, normal control group; Agm, agmatine treatment group. Scale bar is 200 μm.
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term survival changes with and without agmatine treatment.
For mortality assessment following different occlusion dura-
tions, the animals were sacrificed at 10 minutes, 20 minutes,
and 30 minutes of occlusion. However, long-term effects of
agmatine was also studied by sacrificing the animals at 24, 72,
and 168 hours (each, n=3) after reperfusion. 
The animal model with 4-VO showed different mortality
rates with or without agmatine treatment (Table 2). The percen-
tages of mortality were recorded on 36.4, 45.5, and 66.7% in
10 minutes of occlusion without agmatine treatment (EC10), 20
minutes of occlusion without agmatine treatment (EC20), and
30 minutes of occlusion without agmatine treatment (EC30)
groups, respectively. The percentages of mortality were 28.6,
37.5, and 40% in 10 minutes of occlusion with agmatine treat-
ment (Agm10), 20 minutes of occlusion with agmatine treat-
ment (Agm20), and 30 minutes of occlusion with agmatine
treatment (Agm30) groups, respectively. Mortality rate was
higher in the experimental control group compared with the
agmatine treatment group. Agmatine reduced not only neu-
ronal death induced by the 4-VO model following different
occlusion and reperfusion durations, but also ameliorated the
animal’s survival following different occlusion durations after
transient global ischemia. 
To study the long-term effects of agmatine, agmatine (100
mg/kg, IP) was injected daily with reperfusion on the first day.
Withdrawal of continuous agmatine administration at 24, 72,
and 168 hours (each, n=3) showed no remarkable changes as
compared to normal controls. Body weights steadily increased
in both the normal control (normal) and agmatine treatment
(agm) groups (Fig. 1B). Body temperature was always main-
tained at 37±0.5�C (Fig. 1C). Agmatine did not affect food
intake or the body temperature of animals in any groups. It has
been proven to exhibit low systemic toxicity. 
3. Agmatine has shown the neuroprotective
mechanism by suppressing the expression of
NOS 
The mechanism of neuroprotective effect of agmatine with
NO was investigated by histological assessment of three iso-
forms of NOS, and the formation of peroxynitrite by a react-
ion with NO. 
To study the effect of agmatine on NO, the expression of
nNOS, iNOS, and eNOS were examined in the hippocampus
of the rat brain after 20 minutes of occlusion in 4-VO global
models. Animals were killed by decapitation at 24 and 72
hours (each, n=4) after being exposed to global ischemia. 
The number of nNOS positive neurons was increased at 72
hours after 4-VO without agmatine treatment (EC72) and
decreased at 72 hours after 4-VO with agmatine treatment
(AGM72) in the hippocampal CA1 subregion (Fig. 2A). Simil-
arly, damaged and numerous iNOS-positive neurons were ob-
served in all experimental control groups. The number of iNOS
positive cells was effectively decreased in AGM24 (Fig. 2B).
In contrast, the number of eNOS positive neurons was unchang-
ed in all groups (data not shown). Intraperitoneal administration
of agmatine (100 mg/kg) simultaneously with reperfusion
reduced immunoreactivity for nNOS and iNOS expression
after ischemia.
4. Blockade of nitrotyrosine production by
agmatine after transient global ischemia 
To assess the amount of NO production in tissue samples,
we examined the immunoreactivity for 3-nitrotyrosine, a mar-
ker of peroxynitrite, the reaction product of NO and superoxide.
Global ischemia induced a pronounced increase in nitrotyro-
sine expression in pyramidal neurons of CA1 in the hippocam-
pus. Nitrotyrosine expression was increased in CA1 neurons
at 24 hours after reperfusion, and maintained for 72 hours
postischemia in experimental control groups (Fig. 3). In con-
trast, the increase of nitrotyrosine expression was dramatically
suppressed in the agmatine treatment groups, particularly in
AGM24 and AGM72 in the hippocampus (Fig. 3). 
5. Agmatine protects neurons from transient global
ischemia concerned with ER stress-mediated
apoptosis 
To investigate the effects of agmatine on ER stress, the
expression of ER stress-mediated proteins, heat shock protein
70 (Hsp70), glucose-regulated protein 78 (Grp78), C/EBP
homologous protein (CHOP), and B-cell CLL/lymphoma 2
(Bcl-2), were examined in the hippocampus and cerebral cor-
texes of rat brains after global ischemia by immunoblotting.
The level of Hsp70 was increased and maintained high levels
in all groups (Fig. 4). The level of Grp78 in the Agmatine treat-
ment group after 4-VO global ischemia was higher than experi-
mental control groups, especially at 6 hours (AGM6) and 24
hours (AGM24) of reperfusion after 4-VO with agmatine treat-
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Table 2. Mortality of 4-vessel model in transient global ischemia 
Group Total animal survival animal % of mortality
EC10 11 7 36.4
EC20 11 6 45.5
EC30 9 3 66.7
Agm10 7 5 28.6
Agm20 8 5 37.5
Agm30 5 3 40
EC10, 10 minutes of occlusion; EC20, 20 minutes of occlusion; EC30, 30 minutes
of occlusion; Agm10, 10 minutes of occlusion with agmatine treatment; Agm20,
20 minutes of occlusion with agmatine treatment; Agm30, 30 minutes of occlus-
ion with agmatine treatment 
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ment (Fig. 4). The level of CHOP expression was more in the
agmatine treatment group (Fig. 4). Bcl-2 level was higher in
no agmatine treatment group (EC48) compared with agmatine
treatment group (AGM48) at 48 hours of reperfusion after 4-
VO.
6. Electron microscopic study mediated by ER
stress for transient global ischemia 
Electron microscopy of normal control revealed the presence
of vivid chromatin, distinct nuclear membrane, strong ER struc-
tures, and Golgi apparatus (Fig. 5a, d, and g).
Fig. 2. The expressions of nNOS and
iNOS in the rat hippocampus (CA1)
after global cerebral ischemia with or
without agmatine. The number of
nNOS positive neurons in CA1 of the
hippocampus was decreased in
AGM72 in immunohistochemistry
(A). The number of iNOS positive
neurons in CA1 of the hippocampus
was also significantly decreased in
AGM24 in immunohistochemistry
(B). EC24, 24 hours of reperfusion
after 4 -VO; EC72, 72 hours of reper-
fusion after 4 -VO; AGM24, 24 hours
of reperfusion after 4-VO with agma-
tine treatment; AGM72, 72 hours of
reperfusion after 4 -VO with agma-
tine treatment. Scale bar is 200 μm.
(A)
(B)
EC24 EC72
EC24 EC72
AGM24 AGM72
AGM72AGM24
Our EM study indicated significant morphological changes
in the ER and mitochondria in the experimental control group
(EC), with typical apoptotic patterns of compaction and segre-
gation of chromatin, destruction of ER lumen, and disruption
of mitochondria. After 24 hr of reperfusion without agmatine,
swollen rough ER were prevalent (Fig. 5b, e, and h). Swollen
rough ER and free ribosomes that were released from the ER
found to be increased in EC, whereas the mitochondria and ER
lumen remained morphologically normal at 24 h of agmatine
treatment. However, most of the cells in the agmatine-treated
rat brain showed no significant morphological differences (Fig.
5c, f, and i). 
DISCUSSION
In the present study, we used rat as a model for transient glo-
bal ischemia. Twenty minutes of ischemia resulted in marked
damage to the hippocampus as determined by H & E staining
(Lee et al., 2001). On the other hand, we demonsrated that
intraperitoneal administration of agmatine protected the brain
from ischemic injury. Simultaneously, we found that agmatine
can effectively suppress ER dysfunction in vivo. Moreover, the
present findings indicate that the protective effect of agmatine
on ischemic injury may be mediated in part by restoration of
ER dysfunction. 
In cerebral ischemia, apoptosis is caused by excitotoxicity,
ionic imbalance, oxidative/nitrosative stress, and apoptotic-like
pathways (Love, 1999; Yuan & Yankner, 2000; Droge, 2002;
Lo et al., 2003). In correlation with these events, there is an
significant increase in the generation of NO, resulting from
activation of the NOS on both resident and infiltrating cells
(Blantz et al., 2000). Excessive generation of NO is thought to
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Fig. 3. Immunohistochemistry of nitrotyrosine in postischemic CA1 neuron of rat hippocampus following the reperfusion time course. Nitroty-
rosine expression was significantly decreased by agmatine treatment in the AGM24 and AGM72 groups. NC, normal control group; EC24, 24
hours of reperfusion after 4-VO; EC72, 72 hours of reperfusion after 4-VO; AGM24, 24 hours of reperfusion after 4-VO with agmatine treatment;
AGM72, 72 hours of reperfuion after 4-VO with agmatine treatment. Scale bar is 200 μm.
Fig. 4. The expressions of Hsp70, Grp78, CHOP and Bcl-2 in the rat
hippocampus following global cerebral ischemia using Western blot
analysis. The level of Grp78 was higher in AGM than EC from 6 hours
of reperfusion to 72 hours after 4-VO. NC, normal control group; EC,
experimental control group; AGM, agmatine treatment group; Hsp70,
heat shock protein 70; Grp78, glucose-regulated protein 78; CHOP,
C/EBP homologous protein; Bcl-2, B-cell CLL/lymphoma 2.
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play an important role in ischemic injury (Raghavan & Dikshit,
2004). However, exogenous and endogenous radical scaven-
gers have been demonstrated to suppress nitrosative stress and
thus prevent ischemic injury (Tabor & Tabor, 1984; Siesjo et
Fig. 5. Electron microscopy of rat hippocampal cell injured by ER stress at 24 hours of reperfusion after 4-VO. Electron micrographs show ultra-
structural alterations in individual neurons in the hippocampus. The control hippocampal neuron had a large nucleus, relatively small cytoplasm,
and intact mitochondria, ribosomes on the ER lumen and other organelles. ER structure was severely destroyed and several ribosomes were inner-
vated in the cytoplasm of EC. In contrast, the ER structure of AGM was shown intact, like NC. (A), ×15960; (B), ×37200; (C), ×124800 ori-
ginal magnification. NC, normal control group; EC, experimental control group; AGM, agmatine treatment group.
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(B)
(C)
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al., 1995; Kohno et al., 1997). Agmatine has been shown to
exert a protective effect against cerebral ischemic injury by
blocking NMDA receptor activation and inhibiting NOS acti-
vity (Olmos et al., 1999; Yang & Reis, 1999). However, ample
evidence suggested that ER damage is involved in neuronal
cell death induced by cerebral ischemia (Hori et al., 2002;
Nomura, 2004; Xu et al., 2004). Basing on the available re-
ports, we investigated the effect of agmatine on ER dysfunction
under pathological conditions. 
In the 4-VO global model, we observed a significant de-
crease in the number of nNOS and iNOS positive cells in
agmatine treatment group 24 hr after 20 minutes occlusion.
We already demonstrated in our previous report, agmatine
decreased infract sizes and appeared to reduce nNOS express-
ion to a greater extent than iNOS in the MCAO mouse model
(Kim et al., 2004). There are at least three likely mechanisms
for agmatine neuroprotective activity. Agmatine has been
shown to reduce excitotoxicity in vitro by blocking NMDA
receptor activiation (Olmos et al., 1999; Yang & Reis, 1999).
Agmatine, an α-2 adrenoceptor agonist, has been shown to
protect neurons from injury in vivo and in vitro (Li et al., 1994;
Wei et al., 2002). Lastly, an NOS antagonist and generation
of NO have been implicated in ischemic brain injury (Iadecola,
1997). 
Agmatine also has been shown to be a competitive inhibitor
of both nNOS and iNOS (Regunathan & Piletz, 2003; Kim et
al., 2004). In our present study, we found that the induction of
nNOS and iNOS by global ischemia was inhibited with the
administration of agmatine. Agmatine also effectively reduced
the production of nitrotyrosine in the hippocampus after global
ischemia. 
An important source of oxidative stress-mediated brain
damage is the oxidant reactions caused by the formation of
peroxynitrite, a powerful oxidant that results from the interac-
tion between NO and superoxide. This anion has been shown
to cause cell damage by several mechanisms, including lipid
peroxidation, tyrosine nitration, sulfhydryl oxidation and nitro-
sylation, DNA breakage, etc (Kontos, 2001; Fukunaga & Ka-
wano, 2003). 
In contrast to the toxic effects of nNOS and iNOS, eNOS
mediates vasodilation, inhibites the platelet aggregation and
leukocyte adhesion to the endothelium, which are the benefi-
cial effects that would result in protection following cerebral
ischemia (Moro et al., 2004; Paul, 2004; Raghavan & Dikshit,
2004). In our findings, there were no significant changes in the
number of eNOS positive cells in immunoreactivity.
Our data showed a weak expression in the level of the tran-
scription factor CHOP and inactivation of Grp78 in the ische-
mic hippocampus in rats that underwent twenty minutes of glo-
bal ischemia followed by a given period of recovery. The ob-
tained results indicate that global ischemia caused severe ER
damage and triggered ER stress-associated apoptosis. On the
other hand, agmatine treatment slightly increased the level of
CHOP and strongly activated Grp78 in the hippocampus sup-
porting neuroprotective activity. According to our knowledge,
there have been no reports on the neuroprotective mechanism
of agmatine related to ER stress till now. 
ER stress response activates two transcription factors, CHOP
and NF-kB, whose role in the stress response has not been ful-
ly elucidated (Qi et al., 2004b). C/EBP homologous protein
(CHOP), also known as Growth Arrest and DNA Damage-
inducible gene 153 (GADD153) (Qi et al., 2004b), was first
isolated and screened to identify genes responsive to UV treat-
ment, but subsequent studies have recognized this transcription
factor to be the most sensitive to alterations in the ER culmina-
ting in unfolded protein response (UPR) (Oyadomari & Mori,
2004). Expression of GADD153 is activated by all agents that
up-regulate ER chaperons, and like chaperones, it is induced
by activating transcription factor 6 (ATF6) and activating tran-
scription factor 4 (ATF4) (Oyadomari & Mori, 2004). Several
studies have shown the role of GADD153 in negative regulat-
ion of cell growth and differentiation, and it has also been well
implicated in apoptosis induction (Renata & Alan, 2003). Our
study indicated that GADD153 sensitizes cells to ER stress by
down-regulation of Bcl-2 family and by depletion of gluta-
thione (Kadowaki et al., 2004; Oyadomari & Mori, 2004).
However, it is largely unknown and further investigations are
to be done that how the changes in expression of these target
genes relate to apoptosis in ischemic injury. 
Glucose-regulated protein (Grp) 78 is a molecular chaperone
involved in the UPR, termed the unfolded protein response in
the ER of all eukaryotic cells (Xu et al., 2004). The ER chaper-
one Grp78 binds to the ER luminal domains in both PERK and
IRE1, which serves to repress activation of their cytosolic cat-
alytic domains (Kumar et al., 2003). GRP78, the major sensor
of ER stress, seems to be a promising target in neuroprotection
and cancer therapy, and a well known marker of tumor pro-
gression. Modification of ER stress response can help neurons
withstand the stressful conditions during cerebral ischemia
(Banhegyi et al., 2007). The increase in Grp78 provides signifi-
cant cytoprotection against toxic agents, including thapsigargin
(Reddy et al., 2003).
Bcl-2 is one among several key regulators of apoptosis,
which are essential for proper development, tissue homeostasis,
and protection against foreign pathogens (Paschen, 2003). The
anti-apoptotic function of Bcl-2 can also be regulated through
proteolytic processing and phosphorylation. Bcl-2 may pro-
mote cell survival by interfering with activation of the cyto-
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chrome c/Apaf-1 pathway through stabilization of the mito-
chondrial membrane (Paschen et al., 2003; Verkhratsky &
Toescu, 2003). 
We demonstrated the neuroprotective effects of agmatine
administered simultaneously following reperfusion in global
cerebral ischemia by performimg western blot analysis and
immunohistochemistry. Agmaine has numerous possible path-
ways to inhibit neuronal cell death, but mainly by blocking the
NMDA channel and competitive inhibition of NOS. We focus-
ed on the relation of agmatine to NOS and NO. In addition, an
investigation was done on the possible protective effects of
agmatine against ER dysfunction related NO. Our results indi-
cated that agmatine significantly inhibited ER stress-mediated
apoptotic signals induced by transient global ischemia and
attenuated ER stress in global ischemia. 
Agmatine has recently been shown to inhibit NOS in isolated
rat aorta (Auguet et al., 1995) and in rat brains (Li et al., 1994;
Li et al., 1995). In fact, the inhibitory effect of agmatine on
NO synthesis has been implicated in its inhibitory effect on
morphine abstinence syndrome and in its role as antidepressant
(Auguet et al., 1995; Galea et al., 1996). Agmatine can also
antagonize N-methyl-D-aspartate (NMDA) receptor-induced
effects in hippocampal neurons (Olmos et al., 1999; Yang &
Reis, 1999). Apart from these neuromodulatory roles, agmatine
is a metabolic precursor of polyamines, which by themselves
induce various central effects (Lo et al., 2003). 
It is well established that the rat transient global ischemia
model mimics the condition after transient cardiac arrest and
causes selective neuronal death in vulnerable regions, such as
hippocampal CA1 pyramidal cells, Purkinje cells of the cere-
bellum, and neurons in the third to fifth layers of the cerebral
cortex (Kim et al., 2001; Katsuta et al., 2003). This vulnerabi-
lity has been attributed to numerous factors, such as glutamate
neurotoxicity, calcium accumulation, expression of cell suicide
genes, activation of apoptotic proteins, and mitochondrial
dysfunction (Siesjo et al., 1995). Global cerebral ischemia
triggers activation of apoptotic pathways in neurons destined
to die (Kohno et al., 1997; Sugino et al., 2000). It has been
emphasized on the critical role of mitochondrial dysfunction
in these mechanisms after recirculation. 
The major finding in our current investigation is that agma-
tine protects brain tissue against ischemic injury (Ketteler et
al., 1994; Reyes et al., 1994). This effect appears to be mediat-
ed through inhibiting the expression of nNOS and iNOS and
by inducing the over-expression of Grp78 associated with ER
stress in ischemic insults. 
In conclusion, agmatine may be a promising therapeutic sub-
stance for treatment of cerebral ischemia. Considering the find-
ings of the present study, we speculate that agmatine has mul-
tiple effects, although the mechanism of its actions needs to
be elucidated further. 
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